TABLE 1.
n | % | ||
---|---|---|---|
Age | Adult | 383 | 98.2 |
Pediatric | 7 | 1.8 | |
Total | 390 | ||
Lineage | Astrocytoma | 316 | 81 |
Oligodendroglioma | 33 | 8.5 | |
Glioma NOS | 41 | 10.5 | |
Total | 390 | ||
High vs Low grade | High-grade | 317 | 83.6 |
Low-grade | 62 | 16.4 | |
Total | 379 | ||
WHO Grade | I | 6 | 1.7 |
II | 52 | 14.6 | |
III | 62 | 17.4 | |
IV | 237 | 66.4 | |
Total | 357 | ||
IDH-1 status | Wild-type | 266 | 71.9 |
Mutant | 104 | 28.1 | |
Total | 370 | ||
IDH-2 status | Wild-type | 358 | 98.6 |
Mutant | 5 | 1.4 | |
Total | 363 | ||
Tumor location | Frontal | 113 | 35.5 |
Temporal | 96 | 30.2 | |
Parietal | 57 | 17.9 | |
Occipital | 11 | 3.5 | |
Posterior fossa | 11 | 3.5 | |
Other | 19 | 6 | |
Frontotemporal | 2 | 0.6 | |
Frontoparietal | 3 | 0.9 | |
Temporoparietal | 3 | 0.9 | |
Parieto-occipital | 3 | 0.9 | |
Total | 318 |
NOS, not otherwise specified.